Latest Emergency contraception Stories
TOKYO, May 23, 2011 /PRNewswire-FirstCall/ -- Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), the biopharmaceutical company, today announced that Sosei Co., Ltd., its wholly owned Japanese subsidiary, will launch its emergency contraceptive pill, NorLevo(R) TABLETS 0.75mg, tomorrow 24 May, through the distribution network of its commercialization partner, ASKA Pharmaceutical Co., Ltd. NorLevo(R) is an oral emergency contraceptive, which is taken within 72 hours after...
A new study finds that more US women seem to be using the "morning-after" pill now that the emergency contraceptive is available over-the-counter.
Drospirenone, the top-selling oral contraceptive marketed as Yaz or Yasmin in the U.S. and Canada, doesn't carry any more risk of gall bladder disease than the older generation of birth control pills, despite claims by some consumers and lawyers in both countries.
WASHINGTON, April 5, 2011 /PRNewswire-USNewswire/ -- The American Center for Law and Justice (ACLJ), focusing on constitutional law, today secured a sweeping victory for pro-life pharmacy owners in Illinois after a legal battle lasting six years.
Rates of unintended pregnancies and abortions decrease significantly when women receive a one-year supply of oral contraceptives, instead of being prescribed one- or three-month supplies, a UCSF study shows.
TOKYO, Japan, February 23, 2011 /PRNewswire-FirstCall/ -- Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), the biopharmaceutical company, today announced that Sosei Co., Ltd., its wholly owned Japanese subsidiary, was granted approval for its emergency contraceptive pill, NorLevo(R) TABLETS 0.75mg, by the Japan Ministry of Health, Labour and Welfare (MHLW).
A new look at medical literature found no link between heart attacks and the so-called mini-pills contrary to indication reported earlier that women on the popular contraceptive have a higher risk of heart disease.
WASHINGTON, Feb. 16, 2011 /PRNewswire-USNewswire/ -- Catholics for Choice is deeply ashamed that one of the groups at the forefront of the continued attacks on Planned Parenthood clinics is the United States Conference of Catholic Bishops.
Teva Pharmaceuticals Industries Ltd, the maker of the Plan-B morning-after pill is set to face the FDA in another debate over whether the contraceptive can be sold without a prescription for younger women and girls.
WASHINGTON, Jan. 12, 2011 /PRNewswire-USNewswire/ -- At a meeting today in the nation's capital of a federal advisory committee on the new health care law, Family Research Council (FRC) expressed its strong opposition to designating abortion as a means of pregnancy-prevention.
- A serpent whose bite was fabled to produce intense thirst.